Dizal (Jiangsu) Pharmaceutical Co., Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Jiangsu China (2017)

Organization Overview

First Clinical Trial
2018
NCT03450330
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Dizal (Jiangsu) Pharmaceutical Co., Ltd. | Dizal Pharmaceuticals | Healthcare Research Network